National Research Corp Stock Today
| NRC Stock | USD 34.03 0.21 0.61% |
Performance0 of 100
| Odds Of DistressLess than 8
|
National Research is trading at 34.03 as of the 24th of April 2024, a -0.61 percent decrease since the beginning of the trading day. The stock's open price was 34.24. National Research has only a 8 % chance of going through financial distress over the next few years, but has generated negative returns over the last 90 days. Equity ratings for National Research Corp are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of May 2023 and ending today, the 24th of April 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 10th of October 1997 | Category Healthcare | Classification Health Care |
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska. The company has 23.85 M outstanding shares of which 183.3 K shares are now shorted by investors with about 2.95 days to cover. More on National Research Corp
Moving together with National Stock
| 0.74 | CVS | CVS Health Corp Earnings Call This Week | PairCorr |
| 0.89 | JNJ | Johnson Johnson Aggressive Push | PairCorr |
| 0.7 | PFE | Pfizer Inc Earnings Call This Week | PairCorr |
Moving against National Stock
| 0.69 | AA | Alcoa Corp Financial Report 17th of July 2024 | PairCorr |
| 0.61 | XOM | Exxon Mobil Corp Earnings Call This Week | PairCorr |
| 0.56 | MMM | 3M Company Earnings Call This Week | PairCorr |
| 0.55 | CVX | Chevron Corp Earnings Call This Week | PairCorr |
| 0.47 | CAT | Caterpillar Earnings Call Tomorrow | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
National Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. National Research's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding National Research or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Lennart Flem | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Old Name | Nrc Ltd. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Providers & Services, Health Care Equipment & Services, Health Care, Health Care, Health Care Providers & Services, Health Information Services, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering National Research report their recommendations after researching National Research's financial statements, talking to executives and customers, or listening in on National Research's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering National Research Corp. The National consensus assessment is calculated by taking the average forecast from all of the analysts covering National Research. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators obtained from National Research's historical financial statements, National Research Corp is not in a good financial situation at this time. It has a very high probability of going through financial hardship in May. Financial strength of National Research Corp is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
National Research's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to National Research's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand National Research's financial leverage. It provides some insight into what part of National Research's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
National Research Corp (NRC) is traded on NASDAQ Exchange in USA. It is located in 1245 Q Street, Lincoln, NE, United States, 68508 and employs 435 people. National Research is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a total capitalization of 817.36 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate National Research's market, we take the total number of its shares issued and multiply it by National Research's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. National Research Corp runs under Health Care Providers & Services sector within Health Care industry. The entity has 23.85 M outstanding shares of which 183.3 K shares are now shorted by investors with about 2.95 days to cover.
National Research Corp has about 32.97 M in cash with 38.11 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.33.
Check National Research Probability Of Bankruptcy
Ownership AllocationNational Research Corp holds a total of 23.85 Million outstanding shares. Over half of National Research's outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that shop for positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in National Research Corp. Please watch out for any change in the institutional holdings of National Research Corp as this could mean something significant has changed or is about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check National Ownership Details
National Stock Price Odds Analysis
What are National Research's target price odds to finish over the current price? Based on a normal probability distribution, the odds of National Research jumping above the current price in 90 days from now is about 98.0%. The National Research Corp probability density function shows the probability of National Research stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon the stock has a beta coefficient of 1.2215. This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, National Research will likely underperform. Additionally, national Research Corp has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of National Research to move above the current price in 90 days from now is about 98.0 (This National Research Corp probability density function shows the probability of National Stock to fall within a particular range of prices over 90 days) .
National Stock Institutional Holders
Institutional Holdings refers to the ownership stake in National Research that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of National Research's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing National Research's value.| Instituion | Recorded On | Shares | |
| Touchstone Capital, Inc. | 2023-12-31 | 251.6 K | |
| Comerica Bank | 2023-12-31 | 155.2 K | |
| Stonepine Asset Management Inc. | 2023-12-31 | 153.1 K | |
| Bank Of New York Mellon Corp | 2023-12-31 | 121.9 K | |
| Charles Schwab Investment Management Inc | 2023-12-31 | 112.6 K | |
| Bank Of America Corp | 2023-12-31 | 106.5 K | |
| Wells Fargo & Co | 2023-12-31 | 98.8 K | |
| Public Employees Retirement System Of Ohio | 2023-12-31 | 87.3 K | |
| Royce & Associates, Lp | 2023-12-31 | 73.6 K | |
| Kayne Anderson Rudnick Investment Management Llc | 2023-12-31 | 2.9 M | |
| Blackrock Inc | 2023-12-31 | 1.1 M |
National Research Historical Income Statement
National Research Corp Income Statement is one of the three primary financial statements used for reporting National's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of National Research Corp revenue and expense. National Research Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, National Research's Total Revenue is projected to increase significantly based on the last few years of reporting. The current year's Gross Profit is expected to grow to about 91 M, whereas Depreciation And Amortization is forecasted to decline to about 3.4 M. View More FundamentalsNational Stock Against Markets
Picking the right benchmark for National Research stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in National Research stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for National Research is critical whether you are bullish or bearish towards National Research Corp at a given time. Please also check how National Research's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in National Research without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Economic Indicators Now
Economic IndicatorsTop statistical indicators that provide insights into how an economy is performing |
| All Next | Launch Module |
National Research Corporate Directors
National Research corporate directors refer to members of a National Research board of directors. The board of directors generally takes responsibility for the National Research's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of National Research's board members must vote for the resolution. The National Research board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| John Nunnelly | Lead Independent Director | Profile | |
| Donald Berwick | Independent Director | Profile | |
| Harald Arnet | Director | Profile | |
| Arun Jain | Managing Director, Non-Independent Executive Director | Profile |
How to buy National Stock?
Before investing in National Research, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in National Research. To buy National Research stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of National Research. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase National Research stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located National Research Corp stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased National Research Corp stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as National Research Corp, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy National Stock please use our How to Invest in National Research guide.
Already Invested in National Research Corp?
The danger of trading National Research Corp is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of National Research is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than National Research. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile National Research Corp is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether National Research Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National Research's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Research Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Research Corp Stock: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National Research Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Complementary Tools for National Stock analysis
When running National Research's price analysis, check to measure National Research's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy National Research is operating at the current time. Most of National Research's value examination focuses on studying past and present price action to predict the probability of National Research's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move National Research's price. Additionally, you may evaluate how the addition of National Research to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |
Is National Research's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National Research. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National Research listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.339 | Dividend Share 0.48 | Earnings Share 1.25 | Revenue Per Share 6.055 | Quarterly Revenue Growth (0) |
The market value of National Research Corp is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National Research's value that differs from its market value or its book value, called intrinsic value, which is National Research's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National Research's market value can be influenced by many factors that don't directly affect National Research's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National Research's value and its price as these two are different measures arrived at by different means. Investors typically determine if National Research is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Research's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.